SPY332.10+5.44 1.67%
DIA268.32+2.84 1.07%
IXIC11,235.19+230.32 2.09%

UPDATE: OpGen Slideshow Presentation For 'Corporate Overview' Shows Slide Describing 'Upcoming milestones, newsflow & catalysts'

Unyvero & Acuitas® rapid molecular tests • FDA clearance decision Acuitas® AMR Gene Panel (isolates) • Clinical data and publications • Clinical trial updates and regulatory

· 10/06/2020 11:56

Unyvero & Acuitas® rapid molecular tests

• FDA clearance decision Acuitas® AMR Gene Panel (isolates)

• Clinical data and publications

• Clinical trial updates and regulatory submissions

• China NMPA approval and launch for Unyvero platform and pneumonia test

• Unyvero A30 RQ partnering opportunities

 

Ares Genetics

• Potential future expansion of the partnership with global IVD corporation (e.g. option for 90 day exclusive negotiation about licensing)

• Further partnering / licensing deal(s)

• Clinical data and publications